|
CSTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.329900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.304400E-02 |
| Normal-vs-Stage2 |
1.702400E-01 |
| Normal-vs-Stage3 |
6.494800E-01 |
| Normal-vs-Stage4 |
9.96810000000181E-05 |
| Stage1-vs-Stage2 |
8.003000E-01 |
| Stage1-vs-Stage3 |
1.086820E-01 |
| Stage1-vs-Stage4 |
3.430200E-02 |
| Stage2-vs-Stage3 |
2.160000E-01 |
| Stage2-vs-Stage4 |
2.010800E-01 |
| Stage3-vs-Stage4 |
1.232300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.122200E-02 |
| Normal-vs-AfricanAmerican |
1.626450E-02 |
| Normal-vs-Asian |
8.780000E-01 |
| Caucasian-vs-AfricanAmerican |
3.612400E-01 |
| Caucasian-vs-Asian |
5.815600E-01 |
| AfricanAmerican-vs-Asian |
2.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.200400E-03 |
| Normal-vs-Female |
7.532000E-01 |
| Male-vs-Female |
1.434230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.335900E-02 |
| Normal-vs-Extreme_Weight |
3.143500E-03 |
| Normal-vs-Obese |
6.908000E-01 |
| Normal-vs-Extreme_Obese |
2.834200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.026800E-01 |
| Normal_Weight-vs-Obese |
2.607000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.565200E-01 |
| Extreme_Weight-vs-Obese |
4.385600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.588200E-01 |
| Obese-vs-Extreme_Obese |
7.287800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.273800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.305200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.370300E-04 |
| Normal-vs-Age(81-100Yrs) |
8.841100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.870400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.331700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.099800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.363200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.786500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.373200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.420400E-02 |
| Normal-VS-Type2 PRCC |
2.910100E-02 |
| Normal-VS-KIRP CIMP |
3.398200E-01 |
| Normal-VS-Unclassified PRCC |
4.597400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.328800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.956600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.178650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.812000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.929900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.237400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.422100E-03 |
| Normal-vs-N1 |
5.770000E-01 |
| Normal-vs-N2 |
1.833050E-01 |
| N0-vs-N1 |
2.992000E-02 |
| N0-vs-N2 |
4.919200E-01 |
| N1-vs-N2 |
1.436840E-01 |
|
|
